# Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)

> **NCT02476201** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 105 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** MPP ON

## Key facts

- **NCT ID:** NCT02476201
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2019-02-13
- **Final completion:** 2019-07
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02476201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02476201, "Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02476201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*